|
Proqr Therapeutics N.V. (PRQR) Évaluation DCF
NL | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
ProQR Therapeutics N.V. (PRQR) Bundle
Vous cherchez à évaluer la valeur intrinsèque de Proqr Therapeutics N.V.? Notre calculatrice PRQR DCF intègre des données réelles avec des options de personnalisation approfondies, vous permettant d'affiner vos prévisions et d'améliorer vos stratégies d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.0 | .0 | 1.4 | 4.2 | 6.8 | 7.8 | 9.0 | 10.4 | 12.0 | 13.8 |
| Revenue Growth, % | 0 | -100 | 0 | 198.15 | 61.36 | 15.34 | 15.34 | 15.34 | 15.34 | 15.34 |
| EBITDA | -180.9 | -141.7 | -57.0 | -58.6 | -25.0 | -4.7 | -5.4 | -6.2 | -7.2 | -8.3 |
| EBITDA, % | -9015.42 | 100 | -4058.2 | -1398.56 | -369.93 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | 2.1 | 2.3 | 2.5 | 2.6 | 2.6 | 6.2 | 7.2 | 8.3 | 9.6 | 11.0 |
| Depreciation, % | 105.85 | 100 | 178.87 | 61.32 | 38.58 | 79.98 | 79.98 | 79.98 | 79.98 | 79.98 |
| EBIT | -183.0 | -144.0 | -59.5 | -61.2 | -27.6 | -4.7 | -5.4 | -6.2 | -7.2 | -8.3 |
| EBIT, % | -9121.27 | 100 | -4237.07 | -1459.89 | -408.5 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 116.2 | 78.7 | 194.6 | 98.4 | 123.4 | 7.8 | 9.0 | 10.4 | 12.0 | 13.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .4 | .0 | 59.4 | 1.3 | 3.4 | 3.9 | 4.6 | 5.3 | 6.1 |
| Account Receivables, % | 0 | 100 | 0 | 1417.79 | 19.47 | 43.89 | 43.89 | 43.89 | 43.89 | 43.89 |
| Inventories | .4 | .4 | .3 | .0 | .0 | 2.1 | 2.5 | 2.9 | 3.3 | 3.8 |
| Inventories, % | 17.59 | 100 | 19.68 | 0.17005 | 0 | 27.49 | 27.49 | 27.49 | 27.49 | 27.49 |
| Accounts Payable | .5 | .2 | .2 | .4 | 1.6 | 2.7 | 3.1 | 3.5 | 4.1 | 4.7 |
| Accounts Payable, % | 23.02 | 100 | 14.11 | 9.71 | 23.66 | 34.1 | 34.1 | 34.1 | 34.1 | 34.1 |
| Capital Expenditure | -.6 | -1.0 | -.5 | -.7 | -1.4 | -1.6 | -1.9 | -2.2 | -2.5 | -2.9 |
| Capital Expenditure, % | -30.01 | 100 | -35.75 | -17.54 | -21.05 | -20.87 | -20.87 | -20.87 | -20.87 | -20.87 |
| Tax Rate, % | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 | -1.1 |
| EBITAT | -183.4 | -144.4 | -59.7 | -61.3 | -27.9 | -4.7 | -5.4 | -6.2 | -7.2 | -8.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -181.8 | -143.8 | -57.1 | -118.3 | 32.5 | -3.3 | -.5 | -.6 | -.7 | -.8 |
| WACC, % | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 | 5.31 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -5.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1 | |||||||||
| Terminal Value | -25 | |||||||||
| Present Terminal Value | -19 | |||||||||
| Enterprise Value | -25 | |||||||||
| Net Debt | -103 | |||||||||
| Equity Value | 78 | |||||||||
| Diluted Shares Outstanding, MM | 81 | |||||||||
| Equity Value Per Share | 0.97 |
What You Will Get
- Editable Forecast Inputs: Easily adjust assumptions (growth %, margins, WACC) to develop various scenarios.
- Real-World Data: ProQR Therapeutics N.V. (PRQR) financial data pre-loaded to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Customizable and Professional: A sleek Excel model that can be tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing efficiency.
Key Features
- Comprehensive Financial Data: Gain access to precise pre-loaded historical figures and future forecasts for ProQR Therapeutics N.V. (PRQR).
- Adjustable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
- Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow evaluations.
- User-Friendly Dashboard: Clear and informative charts and summaries to help you interpret your valuation findings.
- Designed for All Levels: An accessible, intuitive layout tailored for investors, CFOs, and consultants alike.
How It Works
- 1. Download the Template: Obtain and open the Excel file containing ProQR Therapeutics N.V. (PRQR) preloaded data.
- 2. Adjust Key Assumptions: Modify essential inputs such as growth projections, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Explore Different Scenarios: Evaluate various forecasts to understand diverse valuation results.
- 5. Present with Assurance: Deliver professional valuation analyses to reinforce your decision-making.
Why Choose This Calculator for ProQR Therapeutics N.V. (PRQR)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters to suit your specific analysis needs.
- Real-Time Feedback: Observe immediate updates to ProQR’s valuation as you change inputs.
- Preloaded Data: Comes with ProQR’s latest financial information for swift evaluations.
- Relied Upon by Experts: Utilized by investors and analysts for strategic decision-making.
Who Should Use This Product?
- Biotech Investors: Develop comprehensive and accurate valuation models for assessing ProQR Therapeutics (PRQR) investments.
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the biotech sector.
- Consultants and Advisors: Deliver precise valuation insights for clients considering ProQR Therapeutics (PRQR) stock.
- Students and Educators: Utilize real-world biotechnology data to learn and teach financial modeling techniques.
- Healthcare Enthusiasts: Gain insights into how biotech companies like ProQR Therapeutics (PRQR) are valued in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled ProQR Therapeutics N.V. (PRQR) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for ProQR Therapeutics N.V. (PRQR).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.